Using the same methodology on human PCa patients' blood samples, we identified circulating cells expressing EpCAM and cytokeratin 8, the same markers used by Food and Drug Administration (FDA)-cleared automated systems to identify CTCs (CellSearch, Veridex LLC, Raritan, NJ). The gene discussed is KRT8; the disease is posterior cortical atrophy.